The global Medical Tourism Market size is expected to reach USD 75.3 billion by 2030, growing at a CAGR of 25.22% from 2023 to 2030, according to a new report by Grand View Research, Inc. Cardiovascular treatment (coronary artery bypass graft and heart valve transplantation), dental treatment (veneers, implants, and crowns), cosmetic treatment (breast implants and facelifts) and orthopedic treatment (knee & hip reconstruction and spinal surgery), are among the most frequently performed procedures for medical tourists.
Most elective surgeries, such as cosmetic surgery, certain dental surgeries, fertility treatments, and weight loss surgeries, are not covered by insurance companies in the U.S. Limited availability or lack of insurance coverage drives people to seek procedures in countries such as Thailand, India, and Malaysia. Cosmetic surgeries in most countries are considered elective, and therefore, are not covered under health insurance. This results in interested patients seeking treatment options abroad.
Patients can save treatment costs substantially by traveling to countries where such services are provided at lower costs. For instance, according to the American Society of Plastic Surgeons, a breast augmentation procedure average costs around USD 4,500 to USD 5,000 for an individual in the U.S., compared to around USD 3,000 to USD 4,000 in Malaysia. In addition, the cost of IVF treatment in the U.S. is between USD 12,000 and USD 25,000, whereas in Thailand, it is priced at around USD 6,200 and USD 12,000. This price difference has led to an increase in patient arrivals in Asian countries.
Moreover, the option of combining wellness and medical trips with outstanding clinical facilities and traditional medicine therapies is driving many patients to prefer this option. China has emerged as a key destination for travelers seeking stem cell therapies. Stem cell research is banned in several countries. However, it is legal in China and hence tourists consider China for undergoing it legally. The China market is growing rapidly, owing to a globally expanding middle class, an aging population, and an increasing demand for cosmetic surgery.
Advertising is critical in gaining new clients. Similar to many other privately driven sectors, medical tourism requires advertising exposure. Advertising on websites has become the primary source of information for health travelers. Therefore, having more recognized hospitals enhances a country's global standing. The phenomenal increase in health tourism is being accompanied by the establishment of Joint Commission International (JCI)-accredited health centers.
Singapore, for example, has numerous specialist clinics and 22 hospitals, and specialized centers accredited by the JCI, all of which provide high-quality healthcare services. Due to the availability of state-of-the-art facilities, the country is an attractive medical tourism destination in terms of accommodation and housing alternatives.
However, the COVID-19 pandemic adversely impacted the market for medical tourism. It shook the travel and tourism industry to its foundations. Prominent hospital service providers suffered heavy losses in 2020, as COVID-19 pandemic travel restrictions negatively affected health services aimed at medical tourists. A majority of the workforce in this sector suffered economic losses. A sharp decline in the number of patient arrivals due to travel bans and strict regulations heavily impacted the overall market.
Related Press Release@ Medical Tourism Market Report
Medical Tourism Market Report Highlights
Based on treatment, the cosmetic segment held the largest revenue share of 23.9% in 2022. On the other hand, the infertility treatment segment is expected to record the fastest CAGR from 2023 to 2030
In terms of services providers, the private segment dominated the market, and it is likely to continue its dominance with the projected fastest CAGR of 25.86% from 2023 to 2030, owing to the growing number of public hospitals and focused on marketing strategies to attract foreign patients
Turkey was one of the notable markets in terms of revenue in 2022, owing to the high quality of health services and a high number of patient arrivals in the country
The Thailand medical tourism industry is anticipated to grow at a significant CAGR of 27.8% from 2023 to 2030. Popular destinations in Thailand are Bangkok, Phuket, Pattaya, Chiang Moi, Samui, and Hua Hin
Singapore is also among the major medical tourism destination on the global stage. The country is ranked second in the Medical Tourism Index by the Medical Tourism Association, behind Canada. Singapore's private hospitals provide superior healthcare services with highly trained specialists and state-of-the-art infrastructure
Singapore, Colombia, Taiwan, and Spain are among the leading destinations with the highest growth rates. Medical tourism is a significant source of revenue for several countries. They have a sophisticated healthcare infrastructure and a qualified workforce that enables them to serve foreign patients
Thailand is a popular destination for cosmetic procedures, while India is the preferred destination for cardiothoracic and orthopedic procedures. Dental operations are favored in Brazil and Costa Rica
Medical Tourism Market Report Scope
Report Attribute
Details
Market size value in 2023
USD 15.6 billion
Revenue forecast in 2030
USD 75.3 billion
Growth rate
CAGR of 25.2% from 2023 to 2030
Base year for estimation
2022
Historical data
2018 - 2021
Forecast period
2023 - 2030
Request For A Free Consultation@ https://www.grandviewresearch.com/request-free-consultation/1119/rfc
Medical Tourism Market Segmentation
Grand View Research has segmented the global medical tourism market based on treatment type, service provider, and country:
Medical Tourism Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)
Cardiovascular Treatment
Orthopedic Treatment
Cosmetic Treatment
Bariatric Treatment
Dental Treatment
Ophthalmology Treatment
Infertility Treatment
Alternative Medicine
Other Services
Medical Tourism Service Provider Outlook (Revenue, USD Million, 2018 - 2030)
Public
Private
Medical Tourism Country Outlook (Revenue, USD Million, 2018 - 2030)
Thailand
India
Costa Rica
Mexico
Malaysia
Singapore
Brazil
Colombia
Turkey
Taiwan
South Korea
Czech Republic
Spain
China
Australia
Indonesia
Be the first person to like this.
The U.S. Revenue Cycle Management Market size is expected to reach USD 308.2 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 10.3% from 2023 to 2030. Growing data siloes emerging from multiple healthcare functionalities and departments are driving the need to consolidate and streamline unorganized workflows to boost efficiency and productivity in healthcare organizations. Furthermore, the growing trend of digital health and widespread adoption of healthcare IT solutions are anticipated to accelerate market growth. The market growth in the U.S. can also be attributed to the increasing healthcare IT spending and the growing trend of outsourcing RCM systems and services.
Healthcare systems in the U.S. are undergoing significant transformations and readily adopting electronic processes for claims and reimbursement management. The presence of numerous renowned healthcare facilities, increasing healthcare awareness and spending, and the growing digital literacy are expected to support the growth of the market. Favorable regulatory reforms from government agencies and regular technological advancements by market players are expected to boost market growth over the forthcoming years. The growing need for regular technological advancements is driving market players to revise their product development strategies to improve provider-patient relationship in healthcare facilities. Key participants are focusing on collaborations and strategic partnerships with other market players to combine expertise and grow their business footprint.
For instance, in January 2020, R1 RCM, Inc. entered into a strategic partnership with Rush University System for Health (RUSH) to achieve revenue cycle performance excellence and boost innovation in healthcare. As per the agreement, the platform by R1 RCM would be integrated with RUSH’s Epic EMR workflow, which uses enterprise-wide performance analytics and intelligent automation to improve the company’s current revenue cycle operations. In addition, the collaboration would aid R1 RCM to launch its innovation lab, which focuses on value-based care and incorporates advanced analytics to educate other healthcare institutions in preparing for the future healthcare workforce. This partnership is expected to enable significant improvements in serving patients and financial results in the Chicago metropolitan area.
Market players are introducing innovative product solutions to expand their product portfolio and grow their clientele. For instance, in June 2019, Homecare Homebase (HCHB) introduced a new RCM tool that would reduce the burden related to staffing and time-consuming administrative functions, which often restrict the home health agencies from spending more quality time with patients. Moreover, this new tool offers greater transparency into the murky RCM process that is suitable for agency management, by making use of HCHB dashboards and analytical systems. This new tool makes use of extensive knowledge of the billing process, which aids in achieving and maintaining high collection days and reducing outstanding days in accounts receivable (AR), enabling more time with patients.
List of Key Players of U.S. Revenue Cycle Management Market
The SSI Group, Inc.
AllScripts Healthcare, LLC
eClinicalWorks
McKesson Corporation
athenahealth, Inc.
Epic Systems Corporation
NXGN Management, LLC
Oncospark, Inc.
Related Press Release@ U.S. Revenue Cycle Management Market Report
U.S. Revenue Cycle Management Market Report Highlights
The services component segment dominated the market in 2022 owing to the outsourcing of RCM services from third-party vendors with adequate skill set and workforce
By product type, integrated system spearheaded the market in 2022 owing to the growing demand from healthcare organizations for a synchronized single platform to manage financial activities
The web-based delivery mode segment dominated the market in 2022 owing to the cost-effectiveness and rapid deployment associated with these solutions
The hospitals end-user segment led the market in 2022 owing to the presence of well-established hospitals and growing healthcare IT infrastructure
The others physician specialty segment dominated the market in 2022 owing to the increase in insurance coverage policies for other healthcare services
The in-house sourcing segment held the largest revenue share in 2022 owing to the advantages offered such as patient information confidentiality and entire control of coding operations
Based on function, the claims management segment led the market in 2022 owing to the increasing patient volume and the presence of ineffective claim management systems
U.S. Revenue Cycle Management Market Report Scope
Report Attribute
Details
The market size value in 2023
USD 155.6 billion
The revenue forecast in 2030
USD 308.2 billion
Growth Rate
CAGR of 10.3% from 2023 to 2030
The base year for estimation
2022
Historical data
2017 - 2021
Forecast period
2023 - 2030
Request For A Free Consultation@ https://www.grandviewresearch.com/request-free-consultation/5647/rfc
U.S. Revenue Cycle Management Market Segmentation
Grand View Research, Inc. has segmented the U.S. revenue cycle management market on the basis of end user, product type, component, delivery mode, physician specialty, sourcing, and function:
U.S. Revenue Cycle Management End-user Outlook (Revenue, USD Billion, 2016 - 2030)
Hospitals
Physician & Clinical Services
U.S. Revenue Cycle Management Product Type Outlook (Revenue, USD Billion, 2016 - 2030)
Integrated System
Standalone System
U.S. Revenue Cycle Management Component Outlook (Revenue, USD Billion, 2016 - 2030)
Software Solution
Services
U.S. Revenue Cycle Management Delivery Mode Outlook (Revenue, USD Billion, 2016 - 2030)
On-premise
Web-based
Cloud-based
U.S. Revenue Cycle Management Physician Specialty Outlook (Revenue, USD Billion, 2016 - 2030)
Oncology
Cardiology
Anesthesia
Radiology
Pathology
Pain Management
Emergency Service
Others
U.S. Revenue Cycle Management Sourcing Outlook (Revenue, USD Billion, 2016 - 2030)
In-house
External RCM Apps/ Software
Outsourced RCM Services
U.S. Revenue Cycle Management Function Outlook (Revenue, USD Billion, 2016 - 2030)
Product Development
Member Engagement
Network Management
Care Management
Claim Management
Risk and Compliances
Be the first person to like this.
The global Botanical Ingredients Market size is expected to reach USD 281.41 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.9% over the forecast period. The market is expected to be driven by the increasing demand for convenience and functional food products coupled with the advent of clean and natural botanical supplements by key market participants. The food and beverages industry has been one of the biggest application areas for botanical ingredients. They are widely used in various foods & beverages, such as bakery & dairy products, energy drinks, and confectionery products, owing to their unique flavor and health benefits.
Health-conscious consumers prefer food products with high nutritive content. The COVID-19 pandemic has also shifted customer focus towards preventive healthcare with an emphasis on natural and clean products. Thus, food & beverage manufacturers are focusing on fortifying food products with flavorful and nutritive plant-based ingredients, such as tea extracts. Botanical ingredients are sourced from herbs, leaves, spices, flowers, etc. Spices accounted for the highest revenue share in 2022. The increasing trend of experiencing novel food, high usage as a natural ingredient in cosmetic products, and increasing awareness about health benefits associated with it are major factors contributing to the high market share of the spices segment.
The rising demand for health-beneficial products and the introduction of novel food products by processed food companies to expand their product range and differentiate from competitors are factors expected to boost the market growth. The powder form segment accounted for the largest share in 2022. This is due to its high amounts of active ingredients, longer shelf life compared to liquid form, and extensive utilization in various applications, such as bakery, confectionery, sauces, dressings, meat, soy, dairy, dietary supplements, and medicines. Moreover, the powder form is less likely to be contaminated owing to its concentrated nature. Asia Pacific has been experiencing high growth over the past few years.
This trend is expected to continue over the forecast period. In the Asia Pacific region, developing countries, such as China and India, have witnessed exponential growth in the consumption of functional foods and dietary supplements in the last 10 years. The nutraceuticals industry in developed economies, such as Japan and Australia, has shown an upward growth trajectory in the recent past. As a result, Asia Pacific has emerged as a budding market for botanical ingredients, supported by health and wellness trends across various countries.
Related Press Release@ Botanical Ingredients Market Report
Botanical Ingredients Market Report Highlights
The Asia Pacific region is estimated to register the fastest growth rate during the forecast period
Favorable economic policies for advancements in the healthcare industry and consistent demand for novel products are expected to drive the regional market
The spice source segment accounted for the largest volume as well as the revenue share in 2022
The food & beverage application segment held the largest share in 2022 and is expected to witness steady growth in the coming years
This growth is mainly due to the high consumption of packaged foods as a result of rapid urbanization and changing lifestyles
Key players are increasingly consolidating their position in the industry mainly by acquiring small-sized firms. Companies are also focusing on offering tailored products wherein the content or composition of extracts and concentrate is customized
List of Key Players of Botanical Ingredients Market
Indesso
Lipoid Kosmetic AG
The Herbarie at Stoney Hill Farm, Inc.
International Flavors& Fragrances, Inc.
Bell Flavors& Fragrances
Rutland Biodynamics Ltd.
Prakruti Products Pvt. Ltd.
AmbePhytoextracts Pvt. Ltd.
The Green Labs LLC
Berje, Inc.
DSM
Botanical Ingredients Market Report Scope
Report Attribute
Details
Market size value in 2023
USD 175.44 billion
Revenue forecast in 2030
USD 281.41 billion
Growth rate
CAGR 6.9% from 2023 to 2030
Base year for estimation
2022
Historical data
2018 - 2021
Forecast period
2023 - 2030
Request For A Free Consultation@ https://www.grandviewresearch.com/request-free-consultation/450272/rfc
Botanical Ingredients Market Segmentation
Grand View Research has segmented the global botanical ingredients market on the basis of form, source, application, and region:
Botanical Ingredients Form Outlook (Volume, Kilo Tons; Revenue, USD Million, 2018 - 2030)
Powder
Liquid
Botanical Ingredients Source Outlook (Volume, Kilo Tons; Revenue, USD Million, 2018 - 2030)
Herbs
Leaves
Spices
Flowers
Others
Botanical Ingredients Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2018 - 2030)
Food & Beverages
Food
Bakery & Confectionery
Sauces & Dressings
Others
Beverages
Energy Drinks
Sports Drinks
Functional Juices
Others
Dietary Supplements
Personal Care & Cosmetics
Pharmaceuticals
Others
Botanical Ingredients Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Central & South America
Brazil
Argentina
Middle East & Africa
UAE
Saudi Arabia
Be the first person to like this.
The global Workwear Market size is expected to reach USD 27.36 billion by 2030, registering a CAGR of 5.6% over the forecast period, according to a new report by Grand View Research, Inc. The rising safety concerns in industries coupled with the rising incidences of work-related deaths have been creating a high demand for workwear around the world. Over the past few years, numerous companies in the market have been offering workwear with advanced fabric technology and enhanced features, such as lightweight and versatility, which can be used for different work environments. For instance, Scruffs, a U.K.-based apparel supplier, provides softshell jackets made with 100% polyester. This product is waterproof, fully wind-resistant, and enables high mobility.
Mascot International Ltd., another U.K.-based workwear manufacturer, offers safety shoes and boots that are lightweight and have shock-absorbing soles. It has been observed that leading companies are incorporating advanced technologies, such as the Internet of Things (loT), in workwear to offer features like asset tracking systems. For instance, a microcontroller chip fitted inside a loT-incorporated wearable can help collect real-time data about the posture, toxic gas exposure, motion, breathing, and heart rate of the workers, and this information is accessible and visible to the person in charge. This technology enables organizations to ensure workers’ safety by effectively supervising their health conditions. Eniday, an Italy-based company, manufactures workwear with IoT features.
The apparel product segment dominated the global market in 2021 and accounted for the largest share of the global revenue. Growing participation and the inclination of people toward job opportunities are among the major factors driving the growth of the market. Moreover, the easy availability of durable, comfortable as well as customized products is expected to boost the demand for apparel in the coming years. The protective apparel sub-segment is poised to witness exponential growth, particularly generating huge demand from the medical & healthcare industry. Workwear for biological application holds immense potential and has offered lucrative growth opportunities on account of the COVID-19 pandemic giving further push to the segment.
In the biological industry, workwear is used in microbiological laboratories, sewage work, waste treatment, biotechnological production, etc. Thus, the segment is projected to grow at the fastest CAGR during the forecast period. The market is highly fragmented with a major share occupied by a few firms like 3M, Carhartt Inc., Honeywell International Inc., and Kimberly Clark Corp. Key players operating in the market are implementing strategic initiatives, such as product launch, acquisition, and venturing to strengthen their market positions. These strategies also help in increasing their geographical reach, cutting down competition, and gaining additional share in the market. For strategic and financial buyers alike, the most attractive M&A targets will have strong leadership including a deep bench of rising, future leaders.
List of Key Players in Workwear Market
Carhartt, Inc.
Aramark
Alisco Group
Alexandra
A. Lafont SAS
Aditya Birla Group
3M
Ansell ltd
Honeywell International
Kimberly-Clark Corp
Related Press Release@ Workwear Market Report
Workwear Market Report Highlights
The footwear segment is anticipated to grow at the fastest rate over the forecast period. Increasing cases of accidents at workplaces have been boosting the demand for protective shoes across various industries
The improving women to men ratio in the global workforce market, coupled with the increasing participation of women in the corporate sector, is expected to drive the demand for women's workwear
In addition, a rising number of women pursuing higher education worldwide is expected to increase their involvement in the labor force. This, in turn, is likely to positively impact the market for women’s workwear
Asia Pacific is set out to surpass the regional market growth in the years to come. The growing job opportunities in this region are expected to spur the demand for workwear clothing
In addition, the massive growth of the e-commerce industry in this region has increased the availability of a variety of workwear products, thereby supporting market growth
Request For A Free Consultation@ https://www.grandviewresearch.com/request-free-consultation/6198/rfc
Workwear Market Segmentation
Grand View Research has segmented the global workwear market on the basis of product, demography, application, and region:
Workwear Product (Revenue, USD Million, 2017 - 2030)
Apparel
General Workwear
Protective Workwear
Footwear
General Footwear
Protective Footwear
Workwear Demography (Revenue, USD Million, 2017 - 2030)
Men
Women
Workwear Application Outlook (Revenue, USD Million, 2017 - 2030)
Chemical
Power
Food & Beverage
Biological
Others
Workwear Regional Outlook (Revenue, USD Million, 2017 - 2030)
North America
U.S.
Canada
Mexico
Europe
U.K.
Germany
Asia Pacific
China
India
Central & South America
Brazil
Middle East & Africa
Be the first person to like this.
The global Medical Footwear Market size is anticipated to reach USD 12.97 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 5.7% over the forecast period. Increasing cases of foot-related issues, ankle sprain, ulcers, diabetes, and strain and foot pain owing to obesity are expected to fuel the growth of this market. According to the American Podiatric Medical Association (APMA), in 2018, close to 81% of obese people accepted that they have witnessed foot pain and multiple foot and ankle conditions due to overweight.
The men segment led the market and accounted for 57.2% share of the global revenue in 2019. Increasing technological innovation and product launches have been driving the demand for medical footwear. For instance, in 2019, Footwear Unlimited, Inc. brand Baretraps introduced comfortable shoes with Posture+ technology that help the wearer to correct the posture and reduce strain and pressure on knees, toes, and ankle. The shoes come with a supportive heel cup and a built-in orthotic that reduces the foot pain.
The women segment is expected to register the fastest CAGR of 5.9% from 2020 to 2027. Manufacturers have been broadening their product portfolio by launching casual looking shoes for women, which is proliferating the segment growth. For instance, in July 2019, Dr. Comfort, a medical footwear brand, launched an athleisure-style shoe, The Ruth in women’s category, made of full-grain leather and has reduced seam lines, protective toe box, stable outsoles, removable outsoles, and anti-abrasion material to aid durability, stability, and support.
The COVID-19 (coronavirus) outbreak has severely impacted the footwear industry, including medical footwear, with a reduction in demand owing to store closures, lockdown measures, and restriction in imports and exports at the global level. Sales data reported for Amazon between mid-February and mid-March 2020 showed footwear sales fell by an average of 40 percentage points. Consumers have become more conscious of their spending habits and tend to purchase mostly essential products, which is a major challenge for the market.
The online distribution channel is expected to witness the fastest growth over the forecast period. The rising popularity of e-commerce channels among the manufacturers and high internet penetration among millennials, Gen Z, and Gen X have been driving the sale through this channel. E-commerce websites such as Amazon, Flipkart, Orthorest, and Dr. Comfort offer discounts, deals, and new launches, which attract the consumers and fuel the segment growth.
North America dominated the market for medical footwear and accounted for 33.5% share of the global revenue in 2019. The growth of the regional market is powered by an increasing number of people witnessing foot-related issues in the region. According to a report by the American Podiatric Medical Association, 50% of Americans have limited their outdoor activities due to foot pain because of poor design shoes and high impact activities, such as jumping, running, and dancing.
Asia Pacific is expected to register the fastest CAGR of 6.1% from 2020 to 2027. Increasing cases of diabetes in the region are expected to drive the demand for medical footwear. Moreover, people in the countries, including China, India, and Japan, have become more conscious of their health and are willingly purchasing footwear that can offer relief to chronic foot pain.
List of Key Players of Medical Footwear Market
New Balance
Dr. Comfort
Mephisto
Aetrex Worldwide, Inc.
Orthofeet
Duna
Darco International Inc.
Aetrex Worldwide, Inc.
Dr. Zen, Inc.
Gravity Defyer Corp.
Related Press Release@ Medical Footwear Market Report
Medical Footwear Market Report Highlights
The online distribution channel emerged as the fastest distribution channel in 2019 and is expected to maintain its lead throughout the forecast period. The increasing availability of medical footwear of different brands, free delivery, and seasonal discount on e-retailer platforms are among the major reasons fueling the segment growth
The men segment led the market and accounted for 57.2% share of the global revenue in 2019
Asia Pacific is the fastest growing regional market with a CAGR of 6.1% from 2020 to 2027. Growing awareness among people regarding the benefits of medical footwear including increased blood flow, improved mobility, and enhanced foot support is expected to drive the regional market.
Medical Footwear Market Report Scope
Report Attribute
Details
Market size value in 2020
USD 8.12 billion
Revenue forecast in 2027
USD 12.97 billion
Growth Rate
CAGR of 5.7% from 2020 to 2027
Base year for estimation
2019
Historical data
2016 - 2018
Forecast period
2020 - 2027
Request For A Free Consultation @ https://www.grandviewresearch.com/request-free-consultation/450795/rfc
Medical Footwear Market Segmentation
Grand View Research has segmented the global medical footwear market on the basis of end-use, distribution channel, and region:
Medical Footwear End-use Outlook (Revenue, USD Million, 2016 - 2027)
Men
Women
Medical Footwear Distribution Channel Outlook (Revenue, USD Million, 2016 - 2027)
Offline
Online
Medical Footwear Regional Outlook (Revenue, USD Million, 2016 - 2027)
North America
The U.S.
Europe
Germany
The U.K.
France
Asia Pacific
China
India
Central & South America
Brazil
Middle East & Africa
Be the first person to like this.
The global Aerial Work Platform Market size is expected to reach USD 33.78 billion by 2030, registering a CAGR of 8.9% from 2023 to 2030, according to the recent reports of Grand View Research, Inc. The growth of the construction sector, especially in developing countries, has significantly contributed to the expansion of the market. Rapid urbanization, infrastructure development initiatives, and the need to maintain & repair existing structures have created a strong demand for reliable and safe aerial lifts. Aerial work platforms are primarily used in construction and maintenance activities across diverse industries, enabling tasks, such as efficient product placement, storage of goods in warehouses, and various other applications.
The market is influenced by economic conditions and geopolitical factors. Economic downturns, recessions, and fluctuations in currency exchange rates can have a direct impact on construction and infrastructure development projects, resulting in a decrease in demand for AWPs. Moreover, geopolitical tensions, trade disputes, and regulatory uncertainties can disrupt global supply chains, making it difficult for manufacturers to source raw materials and distribute their products efficiently. These factors pose challenges to the market and can affect its overall performance. The functionality and efficiency of AWPs have been significantly enhanced through technological advancements.
Manufacturers are integrating innovative features, such as telescopic booms, articulating arms, self-leveling capabilities, and advanced control systems. These developments have expanded the range of applications for AWPs and improved their overall performance, making them more appealing to end-users. For example, the rise of automated warehouses in developed countries has created a need for numerous single-scissor lifts, double-scissor lifts, and other lifting tables for product and pallet placement. Substantial funding and investments from various e-commerce and logistics companies worldwide in constructing warehouse buildings are expected to contribute significantly to the overall growth of the market.
List of Key Players in Aerial Work Platform Market
AICHI CORPORATION
Advance Lifts, Inc.
Altec Industries
Bronto Skylift
DINOLIFT OY
EdmoLift AB
HAULOTTE GROUP
JLG Industries
Linamar Corporation
MEC
RUNSHARE Heavy Industry Company, Ltd.
Tadano Ltd.
Terex Corporation
WIESE USA
Related Press Release@ Aerial Work Platform Market Report
Aerial Work Platform Market Report Highlights
The boom lifts segment is expected to register the highest CAGR over the forecast period. The growing emphasis on preventive maintenance and adherence to safety regulations is fueling the demand for boom lifts in the industrial sector
Electric AWP is expected to register the highest CAGR of nearly 10.5% over the forecast period. The main application of electric AWPs is indoors due to their superior maneuverability with a smaller turning radius
The less than 20 ft segment is expected to register the highest CAGR of nearly 9.5% over the forecast period. AWPs with lower lifting heights are versatile machines that can be employed in a wide range of applications
The construction sector is expected to register the highest CAGR of approximately 9.5% over the forecast period. Construction sites involve accessing higher heights and majorly use rough terrain aerial platforms
These sites are prone to accidents related to workers operating at high heights. AWPs offer increased safety and flexibility to workers and operators as compared to conventional solutions
Asia Pacific is expected to register the highest CAGR over the forecast period. Rapid development in the logistics, retail, and warehousing sectors in terms of automation is projected to drive the AWP demand in the region
Aerial Work Platform Market Report Scope
Report Attribute
Details
Market size value in 2023
USD 18.55 billion
Revenue forecast in 2030
USD 33.78 billion
Growth rate
CAGR of 8.9% from 2023 to 2030
Base year for estimation
2022
Historical data
2018 - 2021
Forecast period
2023 - 2030
Related Press Release@ https://www.grandviewresearch.com/request-free-consultation/450899/rfc
Aerial Work Platform Market Segmentation
Grand View Research has segmented the global aerial work platform market based on product, propulsion type, lifting height, application, and region:
Aerial Work Platform Product Outlook (Revenue, USD Million, 2018 - 2030) (Volume, Units)
Boom Lifts
Scissor Lifts
Vertical Lifts
Aerial Work Platform Propulsion Type Outlook (Revenue, USD Million, 2018 - 2030)
ICE
Electric
Air
Aerial Work Platform Lifting Height Outlook (Revenue, USD Million, 2018 - 2030)
Less than 20 Ft
21-50 Ft
More than 51 Ft
Aerial Work Platform Application Outlook (Revenue, USD Million, 2018 - 2030)
Construction
Utilities
Logistics & Transportation
Others
Aerial Work Platform Regional Outlook (Revenue, USD Million, 2018 - 2030) (Volume, Units)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
MEA
U.A.E.
Saudi Arabia
South Africa
Rest of MEA
Be the first person to like this.
The global Digital Pathology Market size is expected to reach USD 1.73 billion by 2030, registering a CAGR of 8.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is anticipated to witness exponential growth owing to rising prevalence of chronic diseases aided by increasing demand for accurate diagnostics. Chronic diseases affect nearly one in every three adults. Whereas, according to the CDC, in the U.S., approximately, 51.8% of adults have at least one chronic disease. Digital pathology, including molecular tissue profiling, biobanking, tissue microarray analysis, and molecular biology, plays an important role in the drug development pipeline and companion diagnostics. Growing demand for high-quality tissue samples in tissue-based biomarker research is expected to drive technology adoption over the forecast period.
Increasing adoption of telepathology with the launch of newer versions of the technology, such as in June 2022, Tribun Health launched TeleSlide Patho 5, an online telepathology platform used for providing clinical and timely expertise to patients. Moreover, the market is expected to see intense competition in the near future as companies adopt more stringent strategies to compete. Moreover, technological advancements, such as the digitization of pathology lab makes the specialty more efficient, the specimen more reproducible, and pathologists' work easier. In past few years, several breakthrough advancements have provided a significant boost to market growth.
For instance, in September 2021, Paige received FDA approval for Paige Prostate, an AI solution for the detection of prostate cancer. The product is the first AI-enabled pathology product to gain marketing authorization. This was further followed by the collaboration of F. Hoffmann-La Roche Ltd. with Ibex in October 2021 for the development of artificial intelligence-based pathology applications for the improvement of patient care. Furthermore, major players are adopting strategies like collaborations and partnerships with a focus on technological advancements, such as robotic light microscopy, digital imaging, multiple fiber optic communications, and computerization, to enhance the adoption of digital pathology.
For instance, in December 2022, Deciphex launched Patholytix 3.0, a Digital Research Pathology Platform with an aim to revolutionize tools available for research pathologists and designed to overcome the limits of LIMS software that allows users to effectively manage associated data and samples. Furthermore, with the launch, the company also highlighted features of the new platform that impact workflow and offer simpler and more expedient report creation.
List of Key Players in the Digital Pathology Market
Leica Biosystems Nussloch GmbH (Danaher)
Hamamatsu Photonics, Inc.
Koninklijke Philips N.V.
Olympus Corporation
F. Hoffmann-La Roche Ltd.
Mikroscan Technologies, Inc.
Inspirata, Inc.
Epredia (3DHISTECH Ltd.)
Visiopharm A/S
Huron Technologies International Inc.
ContextVision AB
CellaVision
HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD. (MORPHOGO)
West Medica Produktions- und Handels- GmbH (West Medica)
aetherAI
IBEX (IBEX MEDICAL ANALYTICS)
SigTuple Technologies Private Limited
Morphle Labs, Inc
Bionovation Biotech, Inc.
Related Press Release@ Digital Pathology Market Report
Digital Pathology Market Report Highlights
Based on product, The device segment held the largest share of 51.72% in 2023 and is anticipated to grow at a lucrative growth rate during the projected period. The device segment includes a slide management system and scanner. The segment growth is attributed to the increasing adoption of digital pathology in academic research activities with enhanced resolution
Based on application, Disease diagnosis is anticipated to witness the fastest growth rate from 2024 to 2030 due to an increasing prevalence of chronic diseases and demand for noble diagnosis techniques
In terms of end-use, The hospitals segment dominated the market in 2023 with a share of 36.7% due to the growing incorporation of digital pathologies in healthcare settings for efficient disease diagnosis
North America dominated overall market in 2023 with a share of 40.7%, due to the presence of well-established digital infrastructure and several technological advancements pertaining to the incorporation of technology in healthcare settings
Request For A Free Consultation @ https://www.grandviewresearch.com/request-free-consultation/1397/rfc
Digital Pathology Market Segmentation
Grand View Research has segmented the global digital pathology market based on product, type, application, end-use, and region:
Digital Pathology Product Outlook (Revenue, USD Billion, 2018 - 2030)
Software
Device
Scanners
Slide Management System
Storage System
Digital Pathology Type Outlook (Revenue, USD Billion, 2018 - 2030)
Human Pathology
Veterinary Pathology
Digital Pathology Application Outlook (Revenue, USD Billion, 2018 - 2030)
Drug Discovery & Development
Academic Research
Disease Diagnosis
Cancer Cell Detection
Others
Digital Pathology End-use Outlook (Revenue, USD Billion, 2018 - 2030)
Hospitals
Biotech & Pharma Companies
Diagnostic Labs
Academic & Research Institutes
Digital Pathology Regional Outlook (Revenue, USD Billion, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
ROE
Asia Pacific
Japan
China
India
South Korea
Australia
Thailand
RoAPAC
Latin America
Brazil
Mexico
Argentina
RoLATAM
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Be the first person to like this.
The global Menopause Market size is expected to reach USD 24.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.33% from 2023 to 2030. Increasing awareness regarding menopause-associated health aspects, rising prevalence of post-menopausal syndrome, and high adoption of women’s health apps are expected to boost market growth during the forecast period. Key players in the region are conducting campaigns to create awareness about women’s health and the role of dietary supplements in easing the transition through it. For instance, in October 2021, Klassen, a reproductive mental health specialist, started the campaign, Let’s Talk Menopause, to make women aware of menopausal symptoms and treatment. The campaign started in 200 subway stations in New York and is its first-of-kind campaign in the U.S.
Rising research supporting the benefits of the dietary supplements than the HRT is projected to drive the market. There are various dietary supplements available in the market containing ingredients such as soy isoflavones, black cohosh, red clover, and amberen. Manufacturers are involved in the launch of new products for managing menopausal symptoms. For instance, in December 2021, Doctor’s Seaweed’s Weed and Wonderful, a U.K.-based food startup, launched seaweed-based supplements for menopause, which are organic and contain nutrients such as iodine and isoflavones.
The pandemic slowed down the market growth as the focus of pharmaceutical companies shifted towards the production of drugs and immune supplements for COVID-19. However, the demand for OTC pharma products and dietary supplements increased during the later phase of 2020 because of the postponement of hormonal replacement therapies, delays in physician’s appointments, and the easy availability of OTC drugs from online channels and retail pharmacies. The market is now stabilizing owing to the ease in the restrictions and the rising awareness regarding menopausal manifestation.
Related Press Release@ Menopause Market Report
Menopause Market Report Highlights
The dietary supplements treatment segment dominated the market in terms of revenue share in 2022 and is expected to witness the fastest growth during the forecast period. The factors contributing to segment growth are the rising geriatric population and the launch of innovative products. For instance, Pulmuone, a South-Korea based dietary supplement firm, launched a product containing soybean and hop extracts for the treatment of menopause-related symptoms
The OTC pharma products treatment segment is divided into hormonal and non-hormonal products. Over-the-Counter (OTC) hormone preparations are becoming more common for use by women undergoing menopause. Some of the major products in the segment include Dehydroepiandrosterone (DHEA), ibuprofen, topical progesterone, and melatonin
North America held the largest revenue share in 2022 due to factors such as the growing prevalence of menopausal symptoms. Moreover, an increase in awareness about dietary requirements is leading to a greater demand among older women
Latin America is expected to register the fastest growth rate during the forecast period owing to factors such as rising awareness about women’s health and growing adoption of dietary supplements for menopausal symptoms
In January 2022, Amyris entered into a definitive agreement for the acquisition of the MenoLabs LLC assets. MenoLabs is dedicated to providing products to improve menopause-related health issues
Request For A Free Consultation @ https://www.grandviewresearch.com/request-free-consultation/451469/rfc
Menopause Market Segmentation
Grand View Research has segmented the global menopause market based on treatment and region:
Menopause Treatment Outlook (Revenue, USD Million, 2018 - 2030)
Dietary Supplements
OTC Pharma Products
Hormonal
Non-hormonal
Menopause Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Sweden
Norway
Denmark
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Menopause Market
Bayer AG
Theramex
AbbVie, Inc.
Abbott
Pure Encapsulations, LLC.
Dr. Reddy’s Laboratories Ltd.
Rainbow Light
PADAGIS LLC
Be the first person to like this.
The global Snacks Market size is expected to reach USD 1,844.42 billion by 2030, expanding at 2.8% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The market has witnessed remarkable growth due to shifting food consumption patterns and strategic collaborations between food delivery partners and snack manufacturers. Consumers have a strong preference for snacks made with natural and nutritious ingredients, devoid of artificial additives. Moreover, there is a growing demand for snacks that cater to specific dietary requirements, such as gluten-free, vegan, and organic options. This trend reflects the increasing awareness and emphasis on healthier snacking choices among consumers.
Consumer preferences have undergone a significant shift from unhealthy eating habits to a focus on healthy snacking. In response to this trend, snack product manufacturers are actively introducing new offerings that strike a balance between taste and nutrition. Factors such as lifestyle changes, cultural influences, and increased consumer knowledge and awareness have played a crucial role in shaping the way people approach their eating habits. Notably, the preference for snacking throughout the day has gained traction among consumers in Europe and North America, presenting manufacturers with vast opportunities for growth and innovation in the market.
Savory snacks are expected to showcase tremendous growth during the forecast period. The consumer demand pattern shows their preference for smaller mini-meals, which they may get from a variety of places, including "healthy" vending machines. Although nuts and snack bars are gaining prominence across the product segment, demand for savory foods such as sushi, meat nibbles like jerky, and hand-held wrap sandwiches is also increasing. The market segmented based on distribution channels was dominated by the supermarkets and hypermarkets segment. However, online distribution channels are expected to drive market growth during the forecast period.
Asia Pacific dominated the market in 2022 and is expected to maintain its dominance during the forecast period. Food habits in Asia are being shaped by rising living standards and premiumization. Consumers want new or customized items to fit their lifestyle, which tends to push them away from the three-meal-a-day model and toward the idea of easily available snacking on the go. The snacking habits of millennials are closely linked to their use of social media.
It has become the ideal place for consumers and brands to test and promote innovative ideas leading to market growth in the region. Manufacturers in the region are launching new products to meet the growing demand for snacks. For instance, in December 2022, Bikano, a leading snack, and packaged food manufacturer in India introduced a new 100g pack of their popular Crunchy Munchy snack. It is packed with ingredients like rice flour, potato, moth flour, chickpea flour, and a blend of spices such as cumin powder, garlic powder, and onion powder.
Snack brands are strategically expanding their presence in various regions, ensuring that snacks are readily available to consumers in different markets. This expansion not only enhances convenience but also offers a greater selection of snack options, as consumers can now enjoy a variety of snacks from around the world. The snacks industry is fragmented with the presence of huge global players as well as a rising share of local and regional players.
Related Press Release@ Snacks Market Report
Snacks Market Report Highlights
Savory snacks dominated the market in 2022 as these snacks offer an extensive range of flavors and textures, catering to diverse consumer preferences and ensuring continuous product innovation
Supermarkets and hypermarkets dominated the market in 2022 due to the sheer volume of stores present across the world and the convenient option of having a vast option of product varieties in a single place
Bags & pouches dominated the market in 2022. The cost-effectiveness, sustainability efforts, and versatility in accommodating various snack types contribute to their widespread preference as the packaging option of choice in the snacks industry
Asia Pacific is expected to register the fastest growth during the forecast period. The rapid adoption of online channels and its integration with brick-and-mortar stores for the purchase of snacks is expected to be the major growth driver in this region
Request For A Free Consultation @ https://www.grandviewresearch.com/request-free-consultation/6235/rfc
Snacks Market Report Segmentation
Grand View Research has segmented the global snacks market based on product, packaging, distribution channel, and region:
Snacks Product Outlook (Revenue, USD Billion, 2017 - 2030)
Frozen & Refrigerated
Fruit
Bakery
Savory
Confectionery
Dairy
Others
Snacks Packaging Outlook (Revenue, USD Billion, 2017 - 2030)
Bags & Pouches
Boxes
Cans
Jars
Others
Snacks Distribution Channel Outlook (Revenue, USD Billion, 2017 - 2030)
Supermarkets & Hypermarkets
Convenience Stores
Online
Others
Snacks Regional Outlook (Revenue, USD Billion, 2017 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Asia Pacific
China
India
Japan
Australia & New Zealand
South Korea
Central & South America
Brazil
Middle East & Africa
UAE
South Africa
List of Key Players in the Snacks Market
General Mills, Inc.
PepsiCo
The Kraft Heinz Company
Nestlé
The Kellogg Company
Unilever
Calbee
Intersnack Group GmbH & Co. KG
Conagra Brands, Inc.
ITC Limited
Grupo Bimbo
Danone
Mars, Incorporated
Be the first person to like this.
The global Legal Marijuana Market size is expected to reach USD 102.24 billion by 2030, according to a new study by Grand View Research, Inc. The market is expected to expand at a CAGR of 25.7% from 2024 to 2030. Increase in rate of legalization of marijuana for medicinal and adult-use/recreational marijuana, growing adoption of these products for the treatment of chronic ailments and rise in a number of new product launches are the primary factors responsible for the growth of the market. For instance, in March 2023, Irwin Naturals Inc., a herbal supplement formulator, introduced company's’ new CBD 25mg Softgels in Canada. It is available through the Starseed Medicinal Medical Group platform across the nation.
In April 2022, New Jersey legalized recreational and medical marijuana, and it is being sold at 13 facilities. This move has made New Jersey one of the 18 states in the United States where recreational marijuana is legal. The market is experiencing growth due to the widespread acceptance of cannabis and its high demand. Since its legalization, the use of marijuana in medical treatments has increased, leading to a decrease in the illegal trade of cannabis. According to a study conducted by New York University, the usage of cannabis among individuals aged 50-64 has doubled in the last decade and has now reached 9.0%.
Moreover, price of legal marijuana is lower than medical marijuana, and taxes would be levied on marijuana products after its legalization. Therefore, cultivators are focusing on cultivating marijuana in areas that are exempt from taxes. For instance, in New York, marijuana cultivators are focusing on tribal regions to get exempted from the taxes levied by the government. This is expected to lower the overall cost of cultivation of marijuana in the state, and cultivators can sell marijuana at lower prices. Lower prices of marijuana are further anticipated to boost the adoption of marijuana in the market.
List of Key Players of Legal Marijuana Market
Canopy Growth Corporation
AURORA CANNABIS INC.
Tilray Brands Inc. (Aphria, Inc.)
ABcann Medicinals, Inc. (VIVO Cannabis Inc.)
The Cronos Group
MARICANN INC.
Organigram Holdings Inc.
Lexaria Bioscience
GW Pharmaceuticals (Jazz Pharmaceuticals, Inc.)
Tikun Olam
United Cannabis Corporation
Related Press Release@ Legal Marijuana Market Report
Legal Marijuana Market Report Highlights
By application, medical segment accounted for the largest revenue share of 79.1% in 2023 owing to the high demand among healthcare practitioners and patients for medicinal marijuana.
By product type, oil and tinctures held the largest market share in 2023 owing to low price and ease of accessibility of flowers compared to other products.
In 2023, North America dominated the overall market with a revenue share of 76.0% owing to its large consumer base, North America was among the first regions to legalize the use of medical and recreational cannabis.
Legal Marijuana Market Report Scope
Report Attribute
Details
Market size value in 2024
USD 26.0 billion
Revenue forecast in 2030
USD 102.2 billion
Growth rate
CAGR of 25.7% from 2024 to 2030
Actual data
2018 - 2023
Forecast data
2024 - 2030
Request For A Free Consultation @ https://www.grandviewresearch.com/request-free-consultation/5051/rfc
Legal Marijuana Market Report Segmentation
Grand View Research has segmented the global legal marijuana market on the basis of application, product type, and region:
Legal Marijuana Application Outlook (Revenue, USD Billion, 2018 - 2030)
Medical
Chronic Pain
Cancer
Depression and Anxiety
Arthritis
Diabetes
Glaucoma
Migraines
Epilepsy
Multiple Sclerosis
AIDS
Amyotrophic Lateral Sclerosis
Alzheimer’s
Post-traumatic Stress Disorder (PTSD)
Parkinson's
Tourette’s
Others
Adult Use
Legal Marijuana Product Type Outlook (Revenue, USD Billion, 2018 - 2030)
Flower
Oil & Tinctures
Legal Marijuana Regional Outlook (Revenue, USD Billion, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
U.K.
Italy
Netherlands
Croatia
Poland
Czech Republic
Switzerland
Spain
Asia Pacific
China
Japan
India
New Zealand
Australia
Thailand
Latin America
Brazil
Mexico
Uruguay
Colombia
Middle East and Africa (MEA)
South Africa
Israel
Be the first person to like this.